[Clinical study of the action of Liocausyth].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000700:Analgesics / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D006801:Humans; D007592:Joint Diseases / Q000188:drug therapy*; D008012:Lidocaine / Q000627:therapeutic use*; D008875:Middle Aged; D009437:Neuralgia / Q000188:drug therapy*; D010024:Osteoporosis / Q000188:drug therapy*; D011736:Pyridoxine / Q000627:therapeutic use*; D011804:Quinolines / Q000627:therapeutic use*; D014805:Vitamin B 12 / Q000627:therapeutic use*
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D011804:Quinolines; D008012:Lidocaine; D011736:Pyridoxine; D014805:Vitamin B 12
Contributo clinico sull'azione del Liocausyth.